Credential Qtrade Securities Inc. Age X Therapeutics, Inc. Call Options Transaction History
Credential Qtrade Securities Inc.
- $1.86 Trillion
 - Q1 2024
 
Call Options
	  0 transactions
	
  | Quarter | Operation | Price Per call | calls change | calls Held | SEC Form | 
|---|
About AgeX Therapeutics, Inc.
- Ticker AGE
 - Exchange NYSE
 - Sector Healthcare
 - Industry Biotechnology
 - Shares Outstandng 37,945,100
 - Description
 - AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...